Skip to main content
Beth Israel Deaconess Medical Center
James Kirby | Research Laboratory
Primary menu
  • Home
  • Research
  • About the PI
  • Team
  • Publications
  • Environment
  • Positions
  • News
  • Blog

Contact

Limit of Detection for Rapid Antigen Testing of the SARS-CoV-2 Omicron and Delta Variants of Concern Using Live-Virus Culture.

Stanley, Sydney, Donald J Hamel, Ian D Wolf, Stefan Riedel, Sanjucta Dutta, Elisa Contreras, Cody J Callahan, et al. 2022. “Limit of Detection for Rapid Antigen Testing of the SARS-CoV-2 Omicron and Delta Variants of Concern Using Live-Virus Culture.”. Journal of Clinical Microbiology 60 (5): e0014022.
Publisher's Version
Last updated on 08/16/2024
PubMed

Share

Recent Publications

  • Novel strain of multidrug non-susceptible Neisseria gonorrhoeae in the USA.
  • Cellulitis and bacteremia caused by the fish pathogen,Streptococcus iniae, in an immunocompromised patient: Case report and mini-review of zoonotic disease, lab identification, and antimicrobial susceptibility.
  • Testing for SARS-CoV-2: lessons learned and current use cases.
  • Sars-Cov-2 antigen tests predict infectivity based on viral culture: comparison of antigen, PCR viral load, and viral culture testing on a large sample cohort.
  • A Versatile Nanoluciferase Reporter Reveals Structural Properties Associated with a Highly Efficient, N-Terminal Legionella pneumophila Type IV Secretion Translocation Signal.
  • RND Pump-Mediated Efflux of Amotosalen, a Compound Used in Pathogen Inactivation Technology to Enhance Safety of Blood Transfusion Products, May Compromise Its Gram-Negative Anti-Bacterial Activity.

James-Kirby

Secondary menu
  • About
  • Team
  • Research
  • Publications
  • News
  • X
  • Youtube
  • Instagram
Powered byOpenScholar®Admin Login